Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 13.13 USD -3.17% Market Closed
Market Cap: $434.3m

During the last 3 months Neuropace Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 21% over this period (open performance analysis).

The last transaction was made on Dec 15, 2025 by Morrell Martha , who sold 399.3k USD worth of NPCE shares.

Last Transactions:
Morrell Martha
$-399.3k
Orbimed Advisors Llc
$-2.1m
Morrell Martha
$-1.1m
Kck Ltd.
$-49.5m
Morrell Martha
$-3k
Morrell Martha
$-1.5k
Morrell Martha
$-48k
Kck Ltd.
$-1.2m
Kck Ltd.
$-884.9
Kck Ltd.
$-24.9k
Kck Ltd.
$-22.7k
Kck Ltd.
$-30.7k
Kck Ltd.
$-20.7k
Kck Ltd.
$-45.3k
Kck Ltd.
$-26.1k
Kck Ltd.
$-26.4k
Kck Ltd.
$-16.3k
Kck Ltd.
$-15.3k
Kck Ltd.
$-19.1k
Kck Ltd.
$-38.6k
Kck Ltd.
$-32.7k
Kck Ltd.
$-39.8k
Kck Ltd.
$-23.1k
Kck Ltd.
$-26.4k
Kck Ltd.
$-33.1k
Kck Ltd.
$-32k
Kck Ltd.
$-33.5k
Kck Ltd.
$-38.5k
Kck Ltd.
$-38.7k
Kck Ltd.
$-2.1k
Kck Ltd.
$-5.7k
Kck Ltd.
$-15.1k
View All Transactions

During the last 3 months Neuropace Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 21% over this period (open performance analysis).

The last transaction was made on Dec 15, 2025 by Morrell Martha , who sold 399.3k USD worth of NPCE shares.

Sold
0-3
months
0 USD
0
3-6
months
399.3k USD
1
6-9
months
0 USD
0
9-12
months
2.1m USD
1
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
0
0 USD

Neuropace Inc
Insider Trading Chart

Neuropace Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Neuropace Inc
Last Insider Transactions

Global
Insiders Monitor

Neuropace Inc
Glance View

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

NPCE Intrinsic Value
6.19 USD
Overvaluation 53%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett